The	O
human	O
toll	O
signaling	O
pathway	O
:	O
divergence	O
of	O
nuclear	B-protein
factor	I-protein
kappaB	I-protein
and	O
JNK	B-protein
/SAPK	B-protein
activation	O
upstream	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor-associated	I-protein
factor	I-protein
6	I-protein
(	O
TRAF6	B-protein
)	O
.	O

The	O
human	O
homologue	O
of	O
Drosophila	B-protein
Toll	I-protein
(	O
hToll	B-protein
)	O
is	O
a	O
recently	O
cloned	O
receptor	O
of	O
the	O
interleukin	B-protein
1	I-protein
receptor	I-protein
(	I-protein
IL-1R	I-protein
)	I-protein
superfamily	I-protein
,	O
and	O
has	O
been	O
implicated	O
in	O
the	O
activation	O
of	O
adaptive	O
immunity	O
.	O

Signaling	O
by	O
hToll	B-protein
is	O
shown	O
to	O
occur	O
through	O
sequential	O
recruitment	O
of	O
the	O
adapter	B-protein
molecule	I-protein
MyD88	B-protein
and	O
the	O
IL-1R-associated	B-protein
kinase	I-protein
.	O

Tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor-activated	I-protein
factor	I-protein
6	I-protein
(	O
TRAF6	B-protein
)	O
and	O
the	O
nuclear	B-protein
factor	I-protein
kappaB	I-protein
(	I-protein
NF-kappaB	I-protein
)	I-protein
-inducing	I-protein
kinase	I-protein
(	O
NIK	B-protein
)	O
are	O
both	O
involved	O
in	O
subsequent	O
steps	O
of	O
NF-kappaB	B-protein
activation	O
.	O

Conversely	O
,	O
a	O
dominant	O
negative	O
version	O
of	O
TRAF6	B-protein
failed	O
to	O
block	O
hToll	B-protein
-induced	O
activation	O
of	O
stress-activated	B-protein
protein	I-protein
kinase/c-Jun	I-protein
NH2-terminal	I-protein
kinases	I-protein
,	O
thus	O
suggesting	O
an	O
early	O
divergence	O
of	O
the	O
two	O
pathways	O
.	O

Brief	NULL
Definitive	NULL
Report	NULL
The	NULL
Human	NULL
Toll	NULL
Signaling	NULL
Pathway	NULL
:	NULL
Divergence	NULL
of	NULL
Nuclear	NULL
Factor	NULL
kB	NULL
and	NULL
JNK/	NULL
SAPK	NULL
Activation	NULL
Upstream	NULL
of	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Receptor-associated	NULL
Factor	NULL
6	NULL
(	NULL
TRAF	NULL
)	NULL
By	NULL
Marta	NULL
Muzio	NULL
,	NULL
*	NULL
Gioacchino	NULL
Natoli	NULL
,	NULL
*	NULL
Simona	NULL
Saccani	NULL
,	NULL
*	NULL
Massimo	NULL
Levrero	NULL
,	NULL
*	NULL
and	NULL
Alberto	NULL
Mantovani*s	NULL
From	NULL
the	NULL
*Department	NULL
of	NULL
Immunology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Mario	NULL
N	NULL
egri	NULL
Institute	NULL
,	NULL
I-20157	NULL
Milan	NULL
,	NULL
Italy	NULL
;	NULL
*Istituto	NULL
di	NULL
I	NULL
Clinica	NULL
Media	NULL
,	NULL
Polidinic	NULL
Umberto	NULL
I	NULL
,	NULL
I-00161	NULL
Rome	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
§Department	NULL
of	NULL
Biotechnology	NULL
,	NULL
University	NULL
of	NULL
Bresaa	NULL
,	NULL
25123	NULL
Bresaa	NULL
,	NULL
Italy	NULL
Sum	NULL
m	NULL
ary	NULL
The	NULL
human	NULL
homologue	NULL
of	NULL
Drosophila	NULL
Toll	NULL
(	NULL
hT	NULL
oll	NULL
)	NULL
is	NULL
a	NULL
recently	NULL
cloned	NULL
receptor	NULL
of	NULL
the	NULL
interleukin	NULL
1	NULL
receptor	NULL
(	NULL
IL-1R	NULL
)	NULL
superfamily	NULL
,	NULL
and	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
adaptive	NULL
immunity	NULL
.	NULL

Signaling	NULL
by	NULL
hToll	NULL
is	NULL
shown	NULL
to	NULL
occur	NULL
through	NULL
sequential	NULL
recruitment	NULL
of	NULL
the	NULL
adapter	NULL
molecule	NULL
MyD88	NULL
and	NULL
the	NULL
IL-	NULL
1R-associated	NULL
kinase	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
receptor-activated	NULL
factor	NULL
6	NULL
(	NULL
TRAF6	NULL
)	NULL
and	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
are	NULL
both	NULL
involved	NULL
in	NULL
subsequent	NULL
steps	NULL
of	NULL
NF-KB	NULL
activation	NULL
.	NULL

Conversely	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
TR	NULL
AF6	NULL
failed	NULL
to	NULL
block	NULL
induced	NULL
activation	NULL
of	NULL
stress-activated	NULL
protein	NULL
kinase/	NULL
c-Jun	NULL
NH	NULL
,	NULL
-	NULL
terminal	NULL
kinases	NULL
,	NULL
thus	NULL
suggesting	NULL
an	NULL
early	NULL
divergence	NULL
of	NULL
the	NULL
two	NULL
pathways	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
mmune	NULL
response	NULL
to	NULL
infection	NULL
requires	NULL
the	NULL
production	NULL
of	NULL
cy-	NULL
tokines	NULL
and	NULL
costimulatory	NULL
molecules	NULL
by	NULL
antigen-presenting	NULL
cells	NULL
.	NULL

Distinct	NULL
cell-associated	NULL
receptors	NULL
on	NULL
myelomonocytic	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
CD14	NULL
,	NULL
allow	NULL
the	NULL
recognition	NULL
of	NULL
pathogen-associated	NULL
molecules	NULL
and	NULL
trigger	NULL
natural	NULL
immune	NULL
response	NULL
by	NULL
inducing	NULL
the	NULL
production	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
that	NULL
subsequently	NULL
signal	NULL
to	NULL
activate	NULL
adaptive	NULL
immunity	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
that	NULL
control	NULL
the	NULL
initial	NULL
induction	NULL
of	NULL
these	NULL
signals	NULL
upon	NULL
infection	NULL
have	NULL
been	NULL
explored	NULL
recently	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
a	NULL
novel	NULL
transmembrane	NULL
receptor	NULL
ho-mologous	NULL
to	NULL
the	NULL
Drosophila	NULL
Toll	NULL
,	NULL
human	NULL
Toll	NULL
(	NULL
hToll	NULL
,	NULL
also	NULL
called	NULL
TLR	NULL
4	NULL
)	NULL
,	NULL
has	NULL
been	NULL
cloned	NULL
recently	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

The	NULL
Drosgph-ila	NULL
Toll	NULL
protein	NULL
controls	NULL
the	NULL
potent	NULL
antifungal	NULL
response	NULL
in	NULL
Drosophila	NULL
adults	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Analogously	NULL
,	NULL
hT	NULL
oll	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
signal	NULL
activation	NULL
of	NULL
adaptive	NULL
immunity	NULL
in	NULL
humans	NULL
by	NULL
inducing	NULL
the	NULL
expression	NULL
of	NULL
B7.1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-8	NULL
;	NULL
thus	NULL
,	NULL
it	NULL
represents	NULL
a	NULL
key	NULL
molecule	NULL
for	NULL
the	NULL
switching	NULL
from	NULL
natural	NULL
to	NULL
acquired	NULL
immunity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
biochemical	NULL
transduction	NULL
pathway	NULL
triggered	NULL
by	NULL
hT	NULL
oll	NULL
was	NULL
ill-defined	NULL
(	NULL
2	NULL
)	NULL
.	NULL

hToll	NULL
is	NULL
a	NULL
type	NULL
I	NULL
orphan	NULL
receptor	NULL
with	NULL
an	NULL
extracellular	NULL
portion	NULL
containing	NULL
leucine-rich	NULL
repeats	NULL
,	NULL
and	NULL
a	NULL
cytoplasmic	NULL
domain	NULL
significantly	NULL
similar	NULL
to	NULL
the	NULL
intracellular	NULL
portion	NULL
of	NULL
the	NULL
IL-	NULL
1R	NULL
type	NULL
I	NULL
(	NULL
IL-	NULL
1R1T	NULL
)	NULL
and	NULL
the	NULL
IL-1R	NULL
accessory	NULL
protein	NULL
(	NULL
IL-	NULL
1R	NULL
AcP	NULL
)	NULL
(	NULL
2	NULL
,	NULL
5	NULL
,	NULL
6	NULL
)	NULL
;	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
they	NULL
may	NULL
use	NULL
an	NULL
analogous	NULL
molecular	NULL
framework	NULL
for	NULL
signaling	NULL
.	NULL

IL-1	NULL
triggers	NULL
the	NULL
activation	NULL
of	NULL
distinct	NULL
transcription	NULL
fac-tors	NULL
,	NULL
including	NULL
NF-KB	NULL
and	NULL
c-Jun/	NULL
activator	NULL
protein	NULL
1	NULL
,	NULL
that	NULL
2097	NULL
Toll	NULL
*	NULL
interleukin	NULL
1	NULL
receptor	NULL
*	NULL
nuclear	NULL
factor	NULL
kB	NULL
*	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase/	NULL
subsequently	NULL
drive	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
events	NULL
occurring	NULL
from	NULL
the	NULL
IL-1R	NULL
signaling	NULL
complex	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
activity	NULL
have	NULL
been	NULL
characterized	NULL
recently	NULL
;	NULL
in	NULL
particular	NULL
,	NULL
the	NULL
adapter	NULL
protein	NULL
MyD88	NULL
recruits	NULL
two	NULL
distinct	NULL
putative	NULL
Ser/	NULL
Thr	NULL
kinases	NULL
,	NULL
namely	NULL
IL-	NULL
1R	NULL
-associated	NULL
kinase	NULL
(	NULL
IR	NULL
AK	NULL
)	NULL
and	NULL
IRAK-2	NULL
,	NULL
to	NULL
the	NULL
receptor	NULL
complex	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

IRAK	NULL
and	NULL
IR	NULL
AK-2	NULL
interact	NULL
subsequently	NULL
with	NULL
the	NULL
adapter	NULL
molecule	NULL
TNFR	NULL
-activated	NULL
factor	NULL
(	NULL
TRAF	NULL
)	NULL
6	NULL
,	NULL
which	NULL
bridges	NULL
them	NULL
to	NULL
the	NULL
protein	NULL
kinase	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
(	NULL
8	NULL
,	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
NIK	NULL
activates	NULL
the	NULL
I-kB	NULL
kinase	NULL
complex	NULL
(	NULL
in-cluding	NULL
IKKa	NULL
and	NULL
IKKB	NULL
)	NULL
that	NULL
directly	NULL
phosphorylates	NULL
(	NULL
13-17	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
identified	NULL
and	NULL
molecularly	NULL
ordered	NULL
the	NULL
mediators	NULL
of	NULL
the	NULL
hToll-induced	NULL
NF-KB	NULL
and	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
SAPK	NULL
)	NULL
/	NULL
c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
activation	NULL
cascade	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Expression	NULL
V	NULL
edors	NULL
and	NULL
T	NULL
rnsfetion	NULL
.	NULL

_	NULL
TR	NULL
AFG6-Flag	NULL
,	NULL
ATR	NULL
AFG6-Flag	NULL
(	NULL
or	NULL
TR	NULL
AFG	NULL
298-522	NULL
)	NULL
,	NULL
ATR	NULL
AF2-Flag	NULL
(	NULL
or	NULL
TR	NULL
AF2	NULL
87-501	NULL
)	NULL
,	NULL
MyD88-AU1	NULL
,	NULL
AMyD88-AU1	NULL
(	NULL
or	NULL
MyD88	NULL
152-296	NULL
)	NULL
,	NULL
IRAK	NULL
,	NULL
NIK	NULL
(	NULL
KK-AA	NULL
)	NULL
,	NULL
and	NULL
HA-p46SAPKy-pCDN	NULL
A3	NULL
expression	NULL
vectors	NULL
have	NULL
been	NULL
described	NULL
(	NULL
8	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Expression	NULL
vectors	NULL
for	NULL
NH	NULL
,	NULL
-terminal	NULL
Flag-tagged	NULL
hToll	NULL
and	NULL
AhToll	NULL
(	NULL
amino	NULL
acids	NULL
1-666	NULL
)	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
PCR	NULL
-generated	NULL
cDNA	NULL
fragments	NULL
lacking	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/	NULL
98/	NULL
06/	NULL
2097/05	NULL
$	NULL
2.00	NULL
Volume	NULL
187	NULL
,	NULL
Number	NULL
12	NULL
,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
2097-2101	NULL
http	NULL
:	NULL
//	NULL
www.jem.org	NULL
A	NULL
LPS	NULL
+	NULL
+	NULL
hours	NULL
Q	NULL
2	NULL
4	NULL
8	NULL
204	NULL
38	NULL
C	NULL
CD4/toll	NULL
C	NULL
]	NULL
h-Toll-flag	NULL
39	NULL
-	NULL
N	NULL
Ah-Toll-flag	NULL
h-Toll	NULL
[	NULL
*	NULL
Relative	NULL
NF-	NULL
«	NULL
8	NULL
activation	NULL
0	NULL
0.2	NULL
0.8	NULL
DNA	NULL
(	NULL
micrograms	NULL
)	NULL
3.2	NULL
the	NULL
coding	NULL
sequence	NULL
for	NULL
the	NULL
signal	NULL
peptide	NULL
,	NULL
into	NULL
the	NULL
mammalian	NULL
expression	NULL
vector	NULL
pFlag-CMV-1	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
,	NULL
Roches	NULL
ter	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

CD4/	NULL
Toll	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Human	NULL
embryonic	NULL
293	NULL
or	NULL
293T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
with	NULL
the	NULL
indicated	NULL
plas	NULL
mids	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
supple-mentation	NULL
with	NULL
an	NULL
empty	NULL
vector	NULL
(	NULL
pCDN	NULL
A3	NULL
;	NULL
Invitrogen	NULL
Corp.	NULL
,	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Northem	NULL
Blotting	NULL
Analysis	NULL
.	NULL

Monocytes	NULL
were	NULL
separated	NULL
from	NULL
fresh	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Coimmunopredpitation	NULL
Analysis	NULL
.	NULL

24-36	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
0.5	NULL
ml	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
150	NULL
mM	NULL
NaCI	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
adjusted	NULL
to	NULL
0.7	NULL
M	NULL
NaCl	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
antibodies	NULL
were	NULL
added	NULL
for	NULL
1-4	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
precipitated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

After	NULL
extensive	NULL
washing	NULL
(	NULL
in	NULL
lysis	NULL
buffer	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
0.1	NULL
%	NULL
SDS	NULL
)	NULL
,	NULL
the	NULL
Sepharose	NULL
beads	NULL
were	NULL
boiled	NULL
in	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
eluted	NULL
proteins	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Subsequent	NULL
immunoblotting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

NF-KB	NULL
A	NULL
divation	NULL
Assay	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
transfected	NULL
with	NULL
endothe-lial	NULL
leukocyte	NULL
adhesion	NULL
molecule-Luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
NF-KB	NULL
luc	NULL
;	NULL
0.1	NULL
mg	NULL
)	NULL
,	NULL
pCMV-	NULL
B-galactosidase	NULL
(	NULL
BGal	NULL
;	NULL
0.2	NULL
g	NULL
)	NULL
,	NULL
and	NULL
IL-18	NULL
AcP	NULL
1FLAGH	NULL
Ar	NULL
nex	NULL
@	NULL
ypiytt	NULL
mybas	NULL
+	NULL
rom	NULL
C	NULL
50	NULL
Relative	NULL
NF-kB	NULL
activation	NULL
2098	NULL
h-Toll	NULL
IP	NULL
:	NULL
aFLAG	NULL
BLOT	NULL
:	NULL
«	NULL
FLAG	NULL
+	NULL
MyD8G	NULL
|	NULL
h-Toll	NULL
(	NULL
FLAG	NULL
)	NULL
IP	NULL
:	NULL
«	NULL
FLAG	NULL
BLOT	NULL
:	NULL
aMtyDss	NULL
189	NULL
[	NULL
_	NULL
]	NULL
vector	NULL
Ij	NULL
ayes	NULL
100	NULL
-	NULL
ﬁ-|	NULL
0	NULL
h-Tol-flag+	NULL
TNFR-2+	NULL
A-h-Toll	NULL
Figure	NULL
1.	NULL
hToll	NULL
expression	NULL
and	NULL
induction	NULL
of	NULL
NF-kB	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Human	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/	NULL
ml	NULL
)	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
and	NULL
analyzed	NULL
for	NULL
their	NULL
hToll	NULL
mRNA	NULL
content	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

Two	NULL
distinct	NULL
transcripts	NULL
specific	NULL
for	NULL
hToll	NULL
are	NULL
detected	NULL
and	NULL
induced	NULL
by	NULL
LPS	NULL
stimulation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ectopic	NULL
expression	NULL
of	NULL
hToll-Flag	NULL
and	NULL
CD4/	NULL
Toll	NULL
but	NULL
not	NULL
the	NULL
mutant	NULL
version	NULL
AhToll-Flag	NULL
activate	NULL
NF-kB	NULL
in	NULL
293T	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
NF-B	NULL
reporter	NULL
gene	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Equal	NULL
amounts	NULL
of	NULL
hToll-Flag	NULL
and	NULL
AhToll-Flag	NULL
are	NULL
produced	NULL
upon	NULL
ectopic	NULL
expression	NULL
in	NULL
293T	NULL
cells	NULL
(	NULL
3.2	NULL
jug	NULL
of	NULL
each	NULL
expression	NULL
construct	NULL
were	NULL
used	NULL
for	NULL
this	NULL
experiment	NULL
)	NULL
.	NULL

JP	NULL
,	NULL
Immunoprecipi-tation	NULL
.	NULL

BLOT	NULL
,	NULL
Immunoblotting	NULL
analysis	NULL
.	NULL

the	NULL
indicated	NULL
expression	NULL
vectors	NULL
.	NULL

Relative	NULL
NF-KB	NULL
activity	NULL
was	NULL
calculated	NULL
by	NULL
normalizing	NULL
relative	NULL
luciferase	NULL
activity	NULL
with	NULL
BGal	NULL
activity	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
out	NULL
of	NULL
two	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
with	NULL
similar	NULL
qualitative	NULL
results	NULL
.	NULL

Data	NULL
from	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
or	NULL
triplicate	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SE	NULL
.	NULL

SAPK/JINK	NULL
Activation	NULL
Assay	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
NF-KB	NULL
luc	NULL
(	NULL
0.5	NULL
wg	NULL
)	NULL
,	NULL
HA-p46SAPKy-pCDNA3	NULL
(	NULL
2	NULL
mg	NULL
)	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
expression	NULL
vectors	NULL
.	NULL

48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
containing	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
20	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
fluoride	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
leupeptin	NULL
(	NULL
20	NULL
ml	NULL
)	NULL
,	NULL
and	NULL
aprotinin	NULL
(	NULL
20	NULL
ug/ml	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
protein	NULL
concentration	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
commercial	NULL
Bradford	NULL
protein	NULL
assay	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
each	NULL
lysate	NULL
(	NULL
usually	NULL
500	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
with	NULL
2	NULL
jug	NULL
antiserum	NULL
to	NULL
HA	NULL
(	NULL
rabbit	NULL
polyclonal	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
collected	NULL
by	NULL
protein	NULL
A-Sepharose	NULL
for	NULL
20	NULL
min	NULL
and	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
RIPA	NULL
buffer	NULL
.	NULL

Precipitates	NULL
were	NULL
boiled	NULL
in	NULL
sample	NULL
buffer	NULL
and	NULL
run	NULL
onto	NULL
an	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Finally	NULL
,	NULL
immunoblotting	NULL
was	NULL
performed	NULL
to	NULL
detect	NULL
the	NULL
active	NULL
phosphorylated	NULL
form	NULL
of	NULL
SAPK	NULL
(	NULL
pThr-183/	NULL
pTyr-185	NULL
of	NULL
hJINK1	NULL
)	NULL
,	NULL
or	NULL
SAPK	NULL
as	NULL
a	NULL
control	NULL
,	NULL
by	NULL
using	NULL
specific	NULL
antibodies	NULL
(	NULL
anti-pJINK	NULL
mouse	NULL
monoclonal	NULL
,	NULL
and	NULL
anti-HA	NULL
;	NULL
Figure	NULL
2	NULL
.	NULL

Functional	NULL
and	NULL
structural	NULL
evidence	NULL
of	NULL
MyD88	NULL
recruitment	NULL
to	NULL
the	NULL
hToll	NULL
signaling	NULL
complex	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
alignment	NULL
of	NULL
human	NULL
MyD88	NULL
(	NULL
amino	NULL
acids	NULL
152-296	NULL
)	NULL
,	NULL
hToll	NULL
(	NULL
667-840	NULL
)	NULL
,	NULL
hIL-1RAcP	NULL
(	NULL
391-570	NULL
)	NULL
,	NULL
and	NULL
hIL-1RI	NULL
(	NULL
381-569	NULL
)	NULL
.	NULL

Alignment	NULL
was	NULL
performed	NULL
with	NULL
Clust-all	NULL
software	NULL
.	NULL

Shading	NULL
,	NULL
Identical	NULL
amino	NULL
acids	NULL
with	NULL
a	NULL
score	NULL
<	NULL
3	NULL
.	NULL

Boxes	NULL
,	NULL
Identical	NULL
amino	NULL
acids	NULL
with	NULL
a	NULL
score	NULL
=	NULL
0	NULL
.	NULL

Dots	NULL
,	NULL
Conserved	NULL
amino	NULL
acids	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
IL-	NULL
1R	NULL
I	NULL
to	NULL
signal	NULL
(	NULL
reference	NULL
20	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
MyD88	NULL
associates	NULL
with	NULL
hToll	NULL
but	NULL
not	NULL
with	NULL
a	NULL
truncated	NULL
version	NULL
of	NULL
hToll	NULL
(	NULL
AhToll	NULL
)	NULL
lacking	NULL
the	NULL
cytoplasmic	NULL
region	NULL
sharing	NULL
sequence	NULL
similarity	NULL
with	NULL
MyD88	NULL
.	NULL

293T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
hToll-Flag	NULL
,	NULL
AhToll-Flag	NULL
,	NULL
or	NULL
IL-	NULL
1R	NULL
AcP-Flag	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
together	NULL
with	NULL
AU1-tagged	NULL
MyD88	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
MyD88	NULL
that	NULL
copre-cipitated	NULL
with	NULL
the	NULL
receptors	NULL
was	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
to	NULL
MyD88	NULL
.	NULL

(	NULL
C	NULL
)	NULL
AMyD88	NULL
inhibits	NULL
hToll-induced	NULL
but	NULL
not	NULL
the	NULL
unrelated	NULL
TNFR	NULL
-2-induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

1	NULL
pg	NULL
of	NULL
receptors	NULL
and	NULL
1.5	NULL
pg	NULL
of	NULL
AMyD88	NULL
were	NULL
transfected	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
relative	NULL
receptor-induced	NULL
NF-B	NULL
activity	NULL
.	NULL

+myDes	NULL
A-h-Toll	NULL
(	NULL
FLAG	NULL
)	NULL
IL-1R	NULL
AcP	NULL
(	NULL
FLAG	NULL
h-Toll	NULL
(	NULL
FLAG	NULL
)	NULL
A-h-Toll	NULL
(	NULL
FLAG	NULL
)	NULL
<	NULL
43	NULL
--	NULL
-*	NULL
<	NULL
-MyDas	NULL
-20	NULL
BLOT	NULL
:	NULL
cAU1	NULL
Human	NULL
Toll	NULL
Signaling	NULL
Pathway	NULL
A	NULL
IRAK+	NULL
B	NULL
-	NULL
iraK-2	NULL
(	NULL
Myc	NULL
)	NULL
+	NULL
C	NULL
tz	NULL
--	NULL
--	NULL
r	NULL
--	NULL
8	NULL
st	NULL
z	NULL
CD4/h-Toll	NULL
+	NULL
A	NULL
a	NULL
&	NULL
®	NULL
a	NULL
9	NULL
&	NULL
@	NULL
<	NULL
<	NULL
®	NULL
%	NULL
~	NULL
=	NULL
g	NULL
-	NULL
%	NULL
g	NULL
£	NULL
3	NULL
&	NULL
Lo	NULL
a	NULL
&	NULL
8	NULL
ibo	NULL
Z	NULL
~	NULL
LoZ	NULL
e	NULL
``	NULL
=	NULL
s	NULL
E	NULL
z	NULL
®	NULL
>	NULL
cog	NULL
R	NULL
5	NULL
+	NULL
T	NULL
I	NULL
<	NULL
oR	NULL
&	NULL
&	NULL
3	NULL
3	NULL
&	NULL
4	NULL
3	NULL
&	NULL
4	NULL
a	NULL
~	NULL
a	NULL
P	NULL
7	NULL
f	NULL
_	NULL
97	NULL
-	NULL
)	NULL
27	NULL
~	NULL
tang	NULL
i	NULL
s	NULL
.	NULL

|a	NULL
>	NULL
$	NULL
68	NULL
-	NULL
£	NULL
_	NULL
s	NULL
_	NULL
IP	NULL
:	NULL
cFLAG	NULL
IP	NULL
:	NULL
eFLAG	NULL
4	NULL
BLOT	NULL
:	NULL
alRAK	NULL
BLOT	NULL
:	NULL
aMyc	NULL
A	NULL
5	NULL
Eo	NULL
@	NULL
3	NULL
“	NULL
``	NULL
-	NULL
MB	NULL
97	NULL
-	NULL
$	NULL
Ff	NULL
:	NULL
E	NULL
x	NULL
es	NULL
-	NULL
4	NULL
65	NULL
..	NULL
eus	NULL
eus	NULL
<	NULL
0	NULL
<	NULL
i	NULL
z	NULL
BLOT	NULL
:	NULL
alRAK	NULL
BLOT	NULL
:	NULL
aMyc	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
hToll	NULL
occurs	NULL
through	NULL
IRAK	NULL
,	NULL
TR	NULL
AFG	NULL
,	NULL
and	NULL
NIK	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IR	NULL
AK	NULL
is	NULL
recruited	NULL
to	NULL
hToll	NULL
but	NULL
not	NULL
to	NULL
the	NULL
inactive	NULL
truncated	NULL
version	NULL
of	NULL
hToll	NULL
(	NULL
AhToll	NULL
)	NULL
.	NULL

IL-1R	NULL
AcP	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
and	NULL
analyzed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IR	NULL
AK-2	NULL
binds	NULL
very	NULL
weakly	NULL
to	NULL
hToll	NULL
.	NULL

IL-1RI	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
and	NULL
analyzed	NULL
as	NULL
in	NULL
A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
ATRAFG6	NULL
but	NULL
not	NULL
the	NULL
unrelated	NULL
ATRAF2	NULL
attenuates	NULL
CD4/Toll-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
mutant	NULL
version	NULL
of	NULL
the	NULL
downstream	NULL
molecule	NULL
NIK	NULL
[	NULL
NIK	NULL
(	NULL
KK-AA	NULL
)	NULL
]	NULL
also	NULL
inhibits	NULL
CD4/	NULL
hToll-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
the	NULL
cell	NULL
lysate	NULL
was	NULL
also	NULL
analyzed	NULL
for	NULL
NF-KB	NULL
activation	NULL
as	NULL
above	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
The	NULL
expression	NULL
and	NULL
eventual	NULL
regulation	NULL
of	NULL
specific	NULL
transcripts	NULL
encoding	NULL
for	NULL
hToll	NULL
were	NULL
analyzed	NULL
in	NULL
distinct	NULL
cell	NULL
types	NULL
that	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
natural	NULL
immune	NULL
response	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
human	NULL
monocytes	NULL
were	NULL
separated	NULL
from	NULL
healthy	NULL
donors	NULL
and	NULL
treated	NULL
with	NULL
the	NULL
bacterial	NULL
product	NULL
LPS	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
specific	NULL
transcripts	NULL
for	NULL
hToll	NULL
were	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
were	NULL
induced	NULL
significantly	NULL
after	NULL
treatment	NULL
with	NULL
LPS	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
modulation	NULL
of	NULL
a	NULL
nonclonal	NULL
receptor	NULL
,	NULL
namely	NULL
hToll	NULL
,	NULL
after	NULL
exposure	NULL
to	NULL
infectious	NULL
agents	NULL
may	NULL
play	NULL
a	NULL
regulatory	NULL
role	NULL
in	NULL
the	NULL
natural	NULL
immune	NULL
response	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
PMN	NULL
and	NULL
dendritic	NULL
cells	NULL
also	NULL
transcribed	NULL
hToll	NULL
mRNA	NULL
at	NULL
different	NULL
levels	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

We	NULL
next	NULL
analyzed	NULL
the	NULL
hToll	NULL
signaling	NULL
pathway	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
.	NULL

A	NULL
chimeric	NULL
version	NULL
of	NULL
hToll	NULL
in	NULL
which	NULL
the	NULL
extra	NULL
cellular	NULL
portion	NULL
was	NULL
substituted	NULL
with	NULL
the	NULL
corresponding	NULL
region	NULL
of	NULL
CD4	NULL
(	NULL
CD4/	NULL
hToll	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
induce	NULL
NF-kB	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

We	NULL
engineered	NULL
distinct	NULL
expression	NULL
constructs	NULL
encoding	NULL
for	NULL
Flag	NULL
epitope-tagged	NULL
hToll	NULL
(	NULL
hToll-Flag	NULL
)	NULL
or	NULL
for	NULL
a	NULL
truncated	NULL
version	NULL
of	NULL
hToll	NULL
that	NULL
lacks	NULL
most	NULL
of	NULL
the	NULL
cytoplasmic	NULL
portion	NULL
(	NULL
AhToll-Flag	NULL
)	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
hToll-Flag	NULL
but	NULL
not	NULL
AhToll-Flag	NULL
induced	NULL
NF-KB	NULL
activation	NULL
in	NULL
human	NULL
embryonic	NULL
293T	NULL
cells	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
the	NULL
CD4/	NULL
Toll	NULL
chimeric	NULL
protein	NULL
that	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

From	NULL
these	NULL
observations	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
either	NULL
CD4-driven	NULL
or	NULL
ectopic	NULL
ex-pression-forced	NULL
aggregation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
portions	NULL
of	NULL
distinct	NULL
hToll	NULL
receptors	NULL
is	NULL
sufficient	NULL
to	NULL
trigger	NULL
a	NULL
signaling	NULL
cas-	NULL
2099	NULL
Muzio	NULL
et	NULL
al	NULL
.	NULL

hToll	NULL
2	NULL
ug	NULL
hToll	NULL
4	NULL
ug	NULL
AhToll	NULL
4	NULL
ug	NULL
TRAFG	NULL
Vector	NULL
hToll	NULL
1	NULL
ug	NULL
hToll	NULL
2	NULL
ug	NULL
+	NULL
MyD88	NULL
(	NULL
152-295	NULL
hToll	NULL
2	NULL
ug	NULL
+	NULL
TRAFG	NULL
(	NULL
280-522	NULL
Vector	NULL
hToll	NULL
2	NULL
ug	NULL
HC	NULL
pJNK	NULL
--	NULL
-	NULL
y=	NULL
HC	NULL
pJNK	NULL
FL	NULL
.	NULL

1	NULL
123	NULL
181	NULL
308	NULL
07	NULL
36.4	NULL
anti-HA	NULL
Ld	NULL
1	NULL
217	NULL
12	NULL
168	NULL
anti-HA	NULL
JNK	NULL
--	NULL
JNK	NULL
--	NULL
anti	NULL
FLAG	NULL
hToll	NULL
--	NULL
ite	NULL
tee	NULL
anti-FLAG	NULL
AhToll	NULL
-	NULL
%	NULL
hToll	NULL
--	NULL
Figure	NULL
4.	NULL
hToll-induced	NULL
SAPK	NULL
activation	NULL
requires	NULL
MyD88	NULL
but	NULL
not	NULL
TR	NULL
AFG	NULL
.	NULL

(	NULL
A	NULL
)	NULL
hToll	NULL
activates	NULL
SAPK/	NULL
JNK	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
active	NULL
phosphorylated	NULL
form	NULL
of	NULL
JNK	NULL
(	NULL
pJINK	NULL
)	NULL
.	NULL

F.1	NULL
.	NULL

,	NULL
Fold	NULL
induction	NULL
calculated	NULL
by	NULL
normalizing	NULL
pJINK	NULL
with	NULL
JNK	NULL
.	NULL

HC	NULL
,	NULL
IgG	NULL
heavy	NULL
chain	NULL
.	NULL

(	NULL
B	NULL
)	NULL
MyD88	NULL
(	NULL
152-296	NULL
)	NULL
(	NULL
AMyD88	NULL
)	NULL
but	NULL
not	NULL
TR	NULL
AFG	NULL
(	NULL
289-522	NULL
)	NULL
(	NULL
ATR	NULL
AF6	NULL
)	NULL
abolishes	NULL
hToll-induced	NULL
SAPK/	NULL
JNK	NULL
phosphorylation	NULL
.	NULL

Fold	NULL
induction	NULL
calculated	NULL
by	NULL
normalizing	NULL
pJINK	NULL
with	NULL
JNK	NULL
.	NULL

HC	NULL
,	NULL
IgG	NULL
heavy	NULL
chain	NULL
.	NULL

cade	NULL
that	NULL
leads	NULL
ultimately	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Given	NULL
this	NULL
,	NULL
one	NULL
could	NULL
speculate	NULL
that	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
hToll	NULL
ligand	NULL
binds	NULL
to	NULL
hToll	NULL
and	NULL
induces	NULL
its	NULL
oli-gomerization	NULL
and	NULL
subsequent	NULL
signaling	NULL
cascade	NULL
,	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
IL-1	NULL
and	NULL
TNF	NULL
with	NULL
their	NULL
cognate	NULL
receptors	NULL
.	NULL

hToll	NULL
shares	NULL
significant	NULL
sequence	NULL
similarity	NULL
with	NULL
distinct	NULL
members	NULL
of	NULL
the	NULL
IL-	NULL
1R	NULL
family	NULL
,	NULL
including	NULL
IL-	NULL
1RI	NULL
,	NULL
IL-	NULL
1R	NULL
AcP	NULL
,	NULL
and	NULL
MyD88	NULL
;	NULL
of	NULL
note	NULL
,	NULL
Phe	NULL
513	NULL
and	NULL
Trp	NULL
514	NULL
in	NULL
IL-	NULL
1RI	NULL
,	NULL
which	NULL
hToll	NULL
TNFR	NULL
MyDs	NULL
$	NULL
DD_	NULL
>	NULL
apoptosis	NULL
IRAK	NULL
TRHLA	NULL
‘	NULL
FZ	NULL
\	NULL
RIP	NULL
a	NULL
TRAF6\	NULL
»	NULL
NIK	NULL
IKK	NULL
alpha	NULL
SAPK/INK	NULL
IKK	NULL
bga	NULL
SAPK/INK	NULL
c-Jun	NULL
I-kB/ANF-kB	NULL
c-Jun	NULL
ATF2	NULL
ATP2	NULL
TCFEKI	NULL
TCBEKI	NULL
cs	NULL
cytokines	NULL
,	NULL
adhesion	NULL
molecules	NULL
...	NULL
.	NULL

Figure	NULL
5	NULL
.	NULL

Overview	NULL
of	NULL
hToll	NULL
and	NULL
TNFR-1	NULL
signaling	NULL
pathways	NULL
.	NULL

The	NULL
diagram	NULL
shows	NULL
that	NULL
the	NULL
bifurcation	NULL
of	NULL
NF-kB	NULL
and	NULL
JNK/	NULL
SAPK	NULL
activation	NULL
by	NULL
hToll	NULL
or	NULL
TNFR	NULL
-1	NULL
occurs	NULL
at	NULL
different	NULL
levels	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
specific	NULL
TRAFs	NULL
.	NULL

TRADD	NULL
,	NULL
TNFR-l-associated	NULL
death	NULL
domain	NULL
.	NULL

RIP	NULL
,	NULL
Receptor-interacting	NULL
protein	NULL
.	NULL

Brief	NULL
Definitive	NULL
R	NULL
eport	NULL
are	NULL
conserved	NULL
in	NULL
all	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
IL-	NULL
1RI	NULL
to	NULL
signal	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
have	NULL
shown	NULL
recently	NULL
a	NULL
homophilic	NULL
interaction	NULL
to	NULL
occur	NULL
between	NULL
the	NULL
IL-1RAcP	NULL
and	NULL
MyD88	NULL
throughout	NULL
their	NULL
ho-mologous	NULL
domains	NULL
(	NULL
8	NULL
)	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
hToll	NULL
and	NULL
the	NULL
adapter	NULL
protein	NULL
MyD88	NULL
could	NULL
interact	NULL
.	NULL

Upon	NULL
coexpression	NULL
,	NULL
MyD88	NULL
and	NULL
hToll	NULL
formed	NULL
an	NULL
immunoprecipitable	NULL
complex	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
a	NULL
mutant	NULL
version	NULL
of	NULL
hToll	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
region	NULL
of	NULL
homology	NULL
to	NULL
MyD88	NULL
and	NULL
which	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
NF-KB	NULL
activation	NULL
,	NULL
failed	NULL
to	NULL
bind	NULL
MyD88	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
)	NULL
.	NULL

A	NULL
mutant	NULL
version	NULL
of	NULL
MyD88	NULL
(	NULL
AMyD88	NULL
)	NULL
,	NULL
encoding	NULL
only	NULL
for	NULL
the	NULL
COOH-terminal	NULL
IL-	NULL
1	NULL
R	NULL
-like	NULL
domain	NULL
,	NULL
abrogates	NULL
IL-1R	NULL
I/	NULL
IL-	NULL
1R	NULL
AcP-induced	NULL
NF-KB	NULL
activation	NULL
(	NULL
8	NULL
)	NULL
;	NULL
given	NULL
this	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
AMyD88	NULL
could	NULL
act	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
inhibitor	NULL
of	NULL
hToll-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

As	NULL
predicted	NULL
,	NULL
AMyD88	NULL
specifically	NULL
inhibited	NULL
hToll-induced	NULL
but	NULL
not	NULL
TNFR	NULL
-2-induced	NULL
NF-KB	NULL
activity	NULL
,	NULL
lending	NULL
functional	NULL
credence	NULL
to	NULL
the	NULL
interaction	NULL
occurring	NULL
between	NULL
hToll	NULL
and	NULL
MyD88	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

From	NULL
these	NULL
observations	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
both	NULL
IL-1R	NULL
and	NULL
hToll	NULL
recruit	NULL
the	NULL
adapter	NULL
protein	NULL
MyD88	NULL
to	NULL
their	NULL
respective	NULL
signaling	NULL
complex	NULL
.	NULL

IR	NULL
AK	NULL
and	NULL
IR	NULL
AK-2	NULL
are	NULL
two	NULL
additional	NULL
proximal	NULL
mediators	NULL
of	NULL
the	NULL
IL-	NULL
1R	NULL
signaling	NULL
complex	NULL
;	NULL
IR	NULL
AK	NULL
is	NULL
recruited	NULL
to	NULL
the	NULL
IL-1R	NULL
AcP	NULL
,	NULL
whereas	NULL
IR	NULL
AK-2	NULL
preferentially	NULL
binds	NULL
IL-1RI	NULL
(	NULL
8	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Given	NULL
this	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
IRAK	NULL
or	NULL
IR	NULL
AK-2	NULL
could	NULL
interact	NULL
with	NULL
hToll	NULL
.	NULL

Upon	NULL
ectopic	NULL
expres-sion	NULL
,	NULL
IRAK	NULL
and	NULL
hToll	NULL
formed	NULL
an	NULL
immunoprecipitable	NULL
complex	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IR	NULL
AK-2	NULL
bound	NULL
only	NULL
weakly	NULL
to	NULL
hToll	NULL
compared	NULL
with	NULL
IL-1RI	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
not	NULL
represent	NULL
a	NULL
relevant	NULL
hToll	NULL
signal	NULL
transducer	NULL
.	NULL

NF-KB	NULL
activation	NULL
induced	NULL
by	NULL
a	NULL
number	NULL
of	NULL
cytokine	NULL
receptors	NULL
is	NULL
mediated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
TR	NULL
AF	NULL
adapter	NULL
fam-ily	NULL
.	NULL

TR	NULL
AF2	NULL
,	NULL
for	NULL
example	NULL
,	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
NF-KB	NULL
activation	NULL
mediated	NULL
by	NULL
TNFR-1	NULL
and	NULL
TNFR-2	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

TR	NULL
AF6	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
IL-1	NULL
signaling	NULL
pathway	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
complex	NULL
with	NULL
IR	NULL
AK	NULL
and	NULL
IR	NULL
AK-2	NULL
downstream	NULL
to	NULL
the	NULL
receptor	NULL
signaling	NULL
complex	NULL
(	NULL
8	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
dominant	NULL
negative	NULL
versions	NULL
of	NULL
either	NULL
could	NULL
act	NULL
to	NULL
inhibit	NULL
hToll-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

ATR	NULL
AFG	NULL
but	NULL
not	NULL
ATR	NULL
AF2	NULL
significantly	NULL
impaired	NULL
hToll-induced	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
TRAFG6	NULL
may	NULL
act	NULL
as	NULL
an	NULL
additional	NULL
downstream	NULL
mediator	NULL
of	NULL
the	NULL
induced	NULL
NF-KB	NULL
activation	NULL
cascade	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
kinase	NULL
NIK	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
general	NULL
mediator	NULL
of	NULL
TRAF-induced	NULL
NF-KB	NULL
activation	NULL
(	NULL
12	NULL
)	NULL
;	NULL
once	NULL
activated	NULL
,	NULL
NIK	NULL
directly	NULL
phosphorylates	NULL
and	NULL
activates	NULL
the	NULL
IKKa/	NULL
B	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
I-kBa	NULL
phos	NULL
phorylation	NULL
and	NULL
subsequent	NULL
NF-KB	NULL
activation	NULL
(	NULL
13-17	NULL
)	NULL
.	NULL

Dominant	NULL
negative	NULL
versions	NULL
of	NULL
NIK	NULL
,	NULL
in	NULL
which	NULL
the	NULL
critical	NULL
lysine	NULL
has	NULL
been	NULL
mutated	NULL
to	NULL
alanine	NULL
[	NULL
NIK	NULL
429-430	NULL
(	NULL
KK-AA	NULL
)	NULL
]	NULL
,	NULL
act	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
activation	NULL
induced	NULL
by	NULL
Fas	NULL
,	NULL
TNF	NULL
,	NULL
and	NULL
IL-1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Given	NULL
this	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
NIK	NULL
(	NULL
KK-AA	NULL
)	NULL
could	NULL
inhibit	NULL
hToll-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

NIK	NULL
(	NULL
KK-AA	NULL
)	NULL
abrogated	NULL
NF-KB	NULL
activity	NULL
triggered	NULL
by	NULL
hToll	NULL
ectopic	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
as	NULL
well	NULL
as	NULL
by	NULL
TR	NULL
AFG	NULL
overexpression	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
inducing	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
distinct	NULL
inflammatory	NULL
cytokines	NULL
also	NULL
induce	NULL
SAPK	NULL
,	NULL
also	NULL
known	NULL
as	NULL
JNK	NULL
.	NULL

The	NULL
active	NULL
phosphorylated	NULL
form	NULL
of	NULL
SAPK	NULL
binds	NULL
to	NULL
and	NULL
phosphorylates	NULL
the	NULL
transcription	NULL
factors	NULL
c-Jun	NULL
,	NULL
activating	NULL
transcription	NULL
factor	NULL
2	NULL
(	NULL
ATF2	NULL
)	NULL
,	NULL
and	NULL
ternary	NULL
complex	NULL
factor	NULL
(	NULL
TCF	NULL
)	NULL
/	NULL
Elk1	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
activation	NULL
of	NULL
SAPK/	NULL
JNK	NULL
by	NULL
the	NULL
TNFR	NULL
-1	NULL
occurs	NULL
through	NULL
a	NULL
TR	NULL
AF2-dependent	NULL
pathway	NULL
,	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
TR	NULL
AF2	NULL
acts	NULL
to	NULL
inhibit	NULL
both	NULL
NF-KB	NULL
and	NULL
c-Jun	NULL
activation	NULL
induced	NULL
by	NULL
TNF	NULL
(	NULL
18	NULL
,	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
NIK	NULL
,	NULL
which	NULL
abrogates	NULL
TNF-induced	NULL
NF-kB	NULL
activation	NULL
,	NULL
fails	NULL
to	NULL
inhibit	NULL
c-Jun	NULL
phosphorylation	NULL
,	NULL
supporting	NULL
a	NULL
model	NULL
wherein	NULL
TNF-mediated	NULL
NF-KB	NULL
and	NULL
c-Jun	NULL
pathways	NULL
bifurcate	NULL
at	NULL
TRAF2	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
hToll	NULL
induced	NULL
SAPK/JNK	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
hToll-Flag	NULL
but	NULL
not	NULL
AhToll-Flag	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
SAPK~y	NULL
as	NULL
indicated	NULL
by	NULL
specific	NULL
phosphorylation	NULL
at	NULL
Thr	NULL
183	NULL
and	NULL
Tyr	NULL
185	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
TR	NULL
AF6	NULL
also	NULL
activated	NULL
SAPK	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
mediators	NULL
of	NULL
hToll-mediated	NULL
JNK	NULL
activation	NULL
,	NULL
we	NULL
cotransfected	NULL
293	NULL
cells	NULL
with	NULL
hToll	NULL
and	NULL
dominant	NULL
negative	NULL
versions	NULL
of	NULL
either	NULL
MyD88	NULL
or	NULL
TRAF6	NULL
.	NULL

Surprisingly	NULL
,	NULL
AMyD88	NULL
but	NULL
not	NULL
ATR	NULL
A6	NULL
acted	NULL
to	NULL
inhibit	NULL
hToll-triggered	NULL
JNK	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
,	NULL
both	NULL
AMyD88	NULL
and	NULL
ATR	NULL
AFG	NULL
abrogated	NULL
hToll-induced	NULL
NF-KB	NULL
activation	NULL
(	NULL
96	NULL
and	NULL
90	NULL
%	NULL
in-hibition	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
ATR	NULL
AFG	NULL
alone	NULL
,	NULL
as	NULL
well	NULL
as	NULL
AMyD88	NULL
,	NULL
failed	NULL
to	NULL
activate	NULL
JNK	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Col-lectively	NULL
,	NULL
these	NULL
observations	NULL
indicate	NULL
that	NULL
although	NULL
ectopic	NULL
expression	NULL
of	NULL
TR	NULL
AF6	NULL
induced	NULL
SAPK	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
version	NULL
of	NULL
TRAF6	NULL
failed	NULL
to	NULL
inhibit	NULL
hToll-induced	NULL
JNK	NULL
phosphorylation	NULL
.	NULL

Given	NULL
this	NULL
,	NULL
one	NULL
could	NULL
speculate	NULL
that	NULL
although	NULL
TR	NULL
AF6	NULL
overexpression	NULL
is	NULL
sufficient	NULL
to	NULL
activate	NULL
JNK/	NULL
SAPK	NULL
,	NULL
endogenous	NULL
TR	NULL
AFG	NULL
does	NULL
not	NULL
provide	NULL
a	NULL
significant	NULL
contribution	NULL
to	NULL
JNK/	NULL
SAPK	NULL
activation	NULL
by	NULL
hToll	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Regardless	NULL
,	NULL
MyD88	NULL
appears	NULL
to	NULL
represent	NULL
the	NULL
most	NULL
upstream	NULL
mediator	NULL
of	NULL
the	NULL
hToll-mediated	NULL
signaling	NULL
cascade	NULL
,	NULL
which	NULL
ultimately	NULL
activates	NULL
NF-KB	NULL
and	NULL
c-Jun	NULL
,	NULL
thus	NULL
driving	NULL
transcriptional	NULL
activation	NULL
of	NULL
several	NULL
cytokines	NULL
and	NULL
costimulatory	NULL
molecules	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
may	NULL
represent	NULL
a	NULL
potentially	NULL
useful	NULL
therapeutic	NULL
target	NULL
for	NULL
controlling	NULL
the	NULL
molecular	NULL
switch	NULL
from	NULL
the	NULL
innate	NULL
to	NULL
the	NULL
adaptive	NULL
immune	NULL
response	NULL
.	NULL

We	NULL
wish	NULL
to	NULL
thank	NULL
R.	NULL
Medzhitov	NULL
and	NULL
C.A	NULL
.	NULL

Janeway	NULL
for	NULL
CD4/	NULL
Toll	NULL
cDNA	NULL
,	NULL
James	NULL
Woodgett	NULL
for	NULL
HA-SAPKy-pCDN	NULL
A3	NULL
,	NULL
and	NULL
Z.	NULL
Cao	NULL
for	NULL
reagents	NULL
and	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

M.	NULL
Muzio	NULL
is	NULL
supported	NULL
by	NULL
Federazione	NULL
Italiana	NULL
Ricerca	NULL
sul	NULL
Cancro	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
European	NULL
Community	NULL
Special	NULL
Project	NULL
Biotechnology	NULL
,	NULL
Consiglio	NULL
Nazionale	NULL
Ricerche	NULL
,	NULL
and	NULL
Associazione	NULL
Italiana	NULL
R	NULL
icerca	NULL
sul	NULL
Cancro	NULL
.	NULL

2100	NULL
Human	NULL
Toll	NULL
Signaling	NULL
Pathway	NULL
Address	NULL
correspondence	NULL
to	NULL
Marta	NULL
Muzio	NULL
,	NULL
Dept	NULL
.	NULL

Immunology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Mario	NULL
Negri	NULL
Institute	NULL
,	NULL
via	NULL
Eritrea	NULL
62	NULL
,	NULL
I-20157	NULL
,	NULL
Milano	NULL
,	NULL
Italy	NULL
.	NULL

Phone	NULL
:	NULL
39-2-39014532	NULL
;	NULL
Fax	NULL
:	NULL
39-2-3546277	NULL
;	NULL
E-mail	NULL
:	NULL
muziom	NULL
@	NULL
irfmn	NULL
.	NULL

mnegri.it	NULL
Received	NULL
for	NULL
publication	NULL
26	NULL
February	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
9	NULL
Apnil	NULL
1998	NULL
.	NULL

References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

Medzhitov	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
Janeway	NULL
,	NULL
Jr.	NULL
1997	NULL
.	NULL

Innate	NULL
immunity	NULL
:	NULL
the	NULL
virtues	NULL
of	NULL
a	NULL
nonclonal	NULL
system	NULL
of	NULL
recognition	NULL
.	NULL

Céll	NULL
91	NULL
:	NULL
295-298.	NULL
.	NULL

Medzhitov	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Preston-Hurlburt	NULL
,	NULL
and	NULL
C.A	NULL
.	NULL

Janeway	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
human	NULL
homologue	NULL
of	NULL
the	NULL
Drosophila	NULL
Toll	NULL
protein	NULL
signals	NULL
activation	NULL
of	NULL
adaptive	NULL
immunity	NULL
.	NULL

Nature	NULL
.	NULL

388:394-397.	NULL
.	NULL

Rock	NULL
,	NULL
FL	NULL
.	NULL

,	NULL
G.	NULL
Hardiman	NULL
,	NULL
J.C.	NULL
Timans	NULL
,	NULL
R	NULL
.	NULL

Kastelein	NULL
,	NULL
and	NULL
F.J.	NULL
Bazan	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
family	NULL
of	NULL
human	NULL
receptors	NULL
structurally	NULL
related	NULL
to	NULL
Drosophila	NULL
Toll	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

95:558-592.	NULL
.	NULL

Lemaitre	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Nicolas	NULL
,	NULL
L.	NULL
Michaut	NULL
,	NULL
J.-M.	NULL
Reichart	NULL
,	NULL
and	NULL
J.A	NULL
.	NULL

Hoffmann	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
dorsoventral	NULL
regulatory	NULL
gene	NULL
cassette	NULL
spatzle/	NULL
Toll	NULL
cactus	NULL
controls	NULL
the	NULL
potent	NULL
antifungal	NULL
response	NULL
in	NULL
Drosophila	NULL
adults	NULL
.	NULL

Cell	NULL
.	NULL

86:973-983.	NULL
.	NULL

Greenfeder	NULL
,	NULL
S.A.	NULL
,	NULL
P.	NULL
Nunes	NULL
,	NULL
L.	NULL
Kwee	NULL
,	NULL
M.	NULL
Labow	NULL
,	NULL
R.A.	NULL
Chizzonite	NULL
,	NULL
and	NULL
G.	NULL
Ju	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
second	NULL
subunit	NULL
of	NULL
the	NULL
interleukin	NULL
1	NULL
receptor	NULL
complex	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:13757-13765.	NULL
.	NULL

Gay	NULL
,	NULL
N.J.	NULL
,	NULL
and	NULL
F.J.	NULL
Keith	NULL
.	NULL

1991	NULL
.	NULL

Drosophila	NULL
Toll	NULL
and	NULL
IL-1	NULL
re	NULL
ceptor	NULL
.	NULL

Nature	NULL
.	NULL

351:355-356.	NULL
.	NULL

Dinarello	NULL
,	NULL
C.A	NULL
.	NULL

1996	NULL
.	NULL

Biologic	NULL
basis	NULL
for	NULL
interleukin-1	NULL
in	NULL
dis	NULL
ease	NULL
.	NULL

Blood	NULL
.	NULL

$	NULL
7:2095-2147.	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Ni	NULL
,	NULL
P.	NULL
Feng	NULL
,	NULL
and	NULL
V.M	NULL
.	NULL

Dixit	NULL
.	NULL

1997	NULL
.	NULL

IRAK	NULL
(	NULL
Pelle	NULL
)	NULL
family	NULL
member	NULL
IR	NULL
AK-2	NULL
and	NULL
MyD88	NULL
as	NULL
proximal	NULL
mediators	NULL
of	NULL
IL-1	NULL
signaling	NULL
.	NULL

Sdene	NULL
278:1612-1615.	NULL
.	NULL

Wesche	NULL
,	NULL
H.	NULL
,	NULL
W.J	NULL
.	NULL

Henzel	NULL
,	NULL
W.	NULL
Shillinglaw	NULL
,	NULL
S.	NULL
Li	NULL
,	NULL
and	NULL
Z.	NULL
Cao	NULL
.	NULL

1997	NULL
.	NULL

MyD88	NULL
:	NULL
an	NULL
adapter	NULL
that	NULL
recruits	NULL
IR	NULL
AK	NULL
to	NULL
the	NULL
IL-1	NULL
receptor	NULL
complex	NULL
.	NULL

Immunity	NULL
.	NULL

7:837-847	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
W.	NULL
Henzel	NULL
,	NULL
and	NULL
X.	NULL
Gao	NULL
.	NULL

1996	NULL
.	NULL

IR	NULL
AK	NULL
:	NULL
:	NULL
a	NULL
kinase	NULL
associated	NULL
with	NULL
the	NULL
interleukin-	NULL
1	NULL
receptor	NULL
.	NULL

Sdare	NULL
271:1128-1131	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Xiong	NULL
,	NULL
M.	NULL
Takeuchi	NULL
,	NULL
T.	NULL
Kurama	NULL
,	NULL
and	NULL
D.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TRAFO6	NULL
is	NULL
a	NULL
signal	NULL
transducer	NULL
for	NULL
interleukin-1	NULL
.	NULL

Nature	NULL
.	NULL

383:443-446	NULL
.	NULL

Malinin	NULL
,	NULL
N.L	NULL
.	NULL

,	NULL
M.P	NULL
.	NULL

Boldin	NULL
,	NULL
A.V	NULL
.	NULL

Kovalenko	NULL
,	NULL
and	NULL
D.	NULL
Wallach	NULL
.	NULL

1997	NULL
.	NULL

MAP3K-related	NULL
kinase	NULL
involved	NULL
in	NULL
NF-KB	NULL
induction	NULL
by	NULL
TNF	NULL
,	NULL
CD95	NULL
and	NULL
IL-1	NULL
.	NULL

Nature	NULL
.	NULL

385:540-544	NULL
.	NULL

DiDonato	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
D.M	NULL
.	NULL

Rothwarf	NULL
,	NULL
E.	NULL
Zandi	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
cytokine-responsive	NULL
IB	NULL
kinase	NULL
that	NULL
activates	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Nature	NULL
388:548-554	NULL
.	NULL

Régnier	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
H.Y	NULL
.	NULL

Song	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
D.V	NULL
.	NULL

Goeddel	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
and	NULL
M.	NULL
R	NULL
othe	NULL
.	NULL

1997	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
Ix-B	NULL
kinase	NULL
.	NULL

Coll	NULL
.	NULL

90:373-383	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Zhu	NULL
,	NULL
BW	NULL
.	NULL

Murray	NULL
,	NULL
A.	NULL
Sheveenko	NULL
,	NULL
BL	NULL
.	NULL

Bennet	NULL
,	NULL
JW	NULL
.	NULL

Li	NULL
,	NULL
D.B	NULL
.	NULL

Young	NULL
,	NULL
M.	NULL
Barbosa	NULL
,	NULL
M.	NULL
Mann	NULL
,	NULL
A.	NULL
Manning	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1997	NULL
.	NULL

IKK-1	NULL
and	NULL
IKK-2	NULL
:	NULL
cytokine-activated	NULL
IB	NULL
kinases	NULL
essential	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Sdene	NULL
.	NULL

278:860-866	NULL
.	NULL

Woroniez	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
X.	NULL
Gao	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
D.	NULL
Goeddel	NULL
.	NULL

1997	NULL
.	NULL

IB	NULL
kinase-	NULL
:	NULL
NF-KB	NULL
activation	NULL
and	NULL
complex	NULL
formation	NULL
with	NULL
IB	NULL
kinase-	NULL
and	NULL
NIK	NULL
.	NULL

Sdence	NULL
.	NULL

278:866-869	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
D.M	NULL
.	NULL

Rothwarf	NULL
,	NULL
M.	NULL
Delhase	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IB	NULL
kinase	NULL
complex	NULL
contains	NULL
two	NULL
ki-	NULL
2101	NULL
Muzio	NULL
et	NULL
al	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
nase	NULL
subunits	NULL
,	NULL
IKKa	NULL
and	NULL
IKKB	NULL
,	NULL
necessary	NULL
for	NULL
IB	NULL
phosphorylation	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

91:243-252	NULL
.	NULL

Natoli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Costanzo	NULL
,	NULL
A.	NULL
Ianni	NULL
,	NULL
D.J	NULL
.	NULL

Templeton	NULL
,	NULL
JR.	NULL
Woodgett	NULL
,	NULL
C.	NULL
Balsano	NULL
,	NULL
and	NULL
M.	NULL
Levrero	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
SAPK/JNK	NULL
by	NULL
TNF	NULL
receptor-1	NULL
through	NULL
a	NULL
noncytotoxic	NULL
TR	NULL
AF2-dependent	NULL
pathway	NULL
.	NULL

Sdene	NULL
275:200-203	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Re	NULL
,	NULL
M.	NULL
Sironi	NULL
,	NULL
N.	NULL
Polentarutti	NULL
,	NULL
A.	NULL
Minty	NULL
,	NULL
D.	NULL
Caput	NULL
,	NULL
P.	NULL
Ferrara	NULL
,	NULL
A.	NULL
Mantovani	NULL
,	NULL
and	NULL
F.	NULL
Colotta	NULL
.	NULL

1994	NULL
.	NULL

Inter-leukin-13	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
interleukin-1	NULL
receptor	NULL
antagonist	NULL
(	NULL
IL-	NULL
1ra	NULL
)	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
mRNA	NULL
for	NULL
the	NULL
intracellular	NULL
(	NULL
keratinocyte	NULL
)	NULL
form	NULL
of	NULL
IL-lra	NULL
in	NULL
human	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

83:1738-1743	NULL
.	NULL

Heguy	NULL
,	NULL
A.	NULL
,	NULL
C.T	NULL
.	NULL

Baldari	NULL
,	NULL
G.	NULL
Macchia	NULL
,	NULL
J.L	NULL
.	NULL

Telford	NULL
,	NULL
and	NULL
M.	NULL
Melli	NULL
.	NULL

1992	NULL
.	NULL

Amino	NULL
acids	NULL
conserved	NULL
in	NULL
interleukin-1	NULL
receptors	NULL
(	NULL
IL-	NULL
1R	NULL
s	NULL
)	NULL
and	NULL
the	NULL
Drosophila	NULL
Toll	NULL
protein	NULL
are	NULL
essential	NULL
for	NULL
IL-	NULL
1R	NULL
signal	NULL
transduction	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

267:2605-2609	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
S.C.	NULL
Wong	NULL
,	NULL
W.J	NULL
.	NULL

Henzel	NULL
,	NULL
and	NULL
D.V	NULL
.	NULL

Goeddel	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
family	NULL
of	NULL
putative	NULL
signal	NULL
transducers	NULL
associated	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
75kDa	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

Cell	NULL
.	NULL

78:681-692	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.M	NULL
.	NULL

Dixit	NULL
,	NULL
and	NULL
D.V	NULL
.	NULL

Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TR	NULL
AF2-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Sdenee	NULL
.	NULL

269:1424-1427	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
I.-H.	NULL
Wu	NULL
,	NULL
T.	NULL
Baret	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
T.	NULL
Deng	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
R	NULL
.	NULL

Davis	NULL
.	NULL

1994	NULL
.	NULL

JINK1	NULL
:	NULL
a	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-R	NULL
as	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
76:1025-1037	NULL
.	NULL

Kyriakis	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
P.	NULL
Banerjee	NULL
,	NULL
E.	NULL
Nikolakaki	NULL
,	NULL
T.	NULL
Dai	NULL
,	NULL
EA	NULL
.	NULL

Ru-bie	NULL
,	NULL
M.F	NULL
.	NULL

Ahmad	NULL
,	NULL
J.	NULL
Avruch	NULL
,	NULL
and	NULL
JR.	NULL
Woodgett	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
subfamily	NULL
of	NULL
c-Jun	NULL
kinases	NULL
.	NULL

Nature	NULL
.	NULL

369:156-160	NULL
.	NULL

Adler	NULL
,	NULL
V.	NULL
,	NULL
A.	NULL
Polotskaya	NULL
,	NULL
F.	NULL
Wagner	NULL
,	NULL
and	NULL
A.S.	NULL
Kraft	NULL
.	NULL

1992	NULL
.	NULL

Affinity-purified	NULL
c-Jun	NULL
amino-terminal	NULL
protein	NULL
kinase	NULL
requires	NULL
serine/threonine	NULL
phosphorylation	NULL
for	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

267:17001-17005	NULL
.	NULL

Reinhard	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Shamoon	NULL
,	NULL
V.	NULL
Shyamala	NULL
,	NULL
and	NULL
LT.	NULL
Williams	NULL
.	NULL

1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
-induced	NULL
activation	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
is	NULL
mediated	NULL
by	NULL
TR	NULL
AF2	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

16:1080-1092	NULL
.	NULL

Liu	NULL
,	NULL
Z.	NULL
,	NULL
H.	NULL
Hsu	NULL
,	NULL
D.V	NULL
.	NULL

Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
1	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-KB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
.	NULL

87:565-576	NULL
.	NULL

Song	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
CH	NULL
.	NULL

Régnier	NULL
,	NULL
C.J	NULL
.	NULL

Kirschining	NULL
,	NULL
D.V	NULL
.	NULL

Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-mediated	NULL
kinase	NULL
cascades	NULL
:	NULL
bifurcation	NULL
of	NULL
NF-KB	NULL
and	NULL
c-jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JINK/SAPK	NULL
)	NULL
pathways	NULL
at	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
2	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aad	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

94:9792-9796	NULL
.	NULL

Natoli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Costanzo	NULL
,	NULL
F.	NULL
Moretti	NULL
,	NULL
M.	NULL
Fulco	NULL
,	NULL
C.	NULL
Balsano	NULL
,	NULL
and	NULL
M.	NULL
Levrero	NULL
.	NULL

1997	NULL
.	NULL

TNF	NULL
receptor-1	NULL
signaling	NULL
downstream	NULL
of	NULL
TR	NULL
AF2	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:26079-26082	NULL
.	NULL

Brief	NULL
Definitive	NULL
R	NULL
eport	NULL

